| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |